Brokerages Set Transcat, Inc. (NASDAQ:TRNS) Price Target at $111.50

Shares of Transcat, Inc. (NASDAQ:TRNS) have been given an average rating of “Hold” by the five ratings firms that are currently covering the stock, Marketbeat Ratings reports. Three analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 1 year price objective among analysts that have issued ratings on the stock in the last year is $111.50.

Several research analysts recently weighed in on TRNS shares. Oppenheimer lowered Transcat from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 29th. Craig Hallum increased their price target on Transcat from $113.00 to $125.00 and gave the stock a “buy” rating in a report on Thursday, December 12th. HC Wainwright reduced their price objective on shares of Transcat from $126.00 to $106.00 and set a “buy” rating on the stock in a report on Wednesday, January 29th. StockNews.com cut shares of Transcat from a “hold” rating to a “sell” rating in a research report on Wednesday, February 5th. Finally, Northland Securities reiterated a “market perform” rating and set a $85.00 price target (down from $110.00) on shares of Transcat in a research report on Wednesday, January 29th.

Transcat Trading Down 1.1 %

Shares of TRNS opened at $71.05 on Wednesday. Transcat has a 12-month low of $67.56 and a 12-month high of $147.12. The firm has a market capitalization of $661.40 million, a P/E ratio of 38.41 and a beta of 0.66. The firm has a 50-day moving average price of $81.59 and a 200 day moving average price of $101.74. The company has a current ratio of 2.42, a quick ratio of 1.98 and a debt-to-equity ratio of 0.14.

Transcat (NASDAQ:TRNS) last posted its quarterly earnings results on Monday, January 27th. The scientific and technical instruments company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.07. Transcat had a net margin of 6.22% and a return on equity of 7.23%. During the same period in the previous year, the business posted $0.56 earnings per share. Sell-side analysts forecast that Transcat will post 2.3 EPS for the current year.

Insider Activity at Transcat

In other news, Director Craig D. Cairns bought 1,200 shares of the company’s stock in a transaction on Friday, January 31st. The stock was bought at an average cost of $77.02 per share, with a total value of $92,424.00. Following the transaction, the director now directly owns 1,910 shares in the company, valued at $147,108.20. The trade was a 169.01 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 2.30% of the company’s stock.

Institutional Trading of Transcat

Several hedge funds have recently made changes to their positions in the business. Principal Financial Group Inc. grew its holdings in shares of Transcat by 8.8% in the third quarter. Principal Financial Group Inc. now owns 4,611 shares of the scientific and technical instruments company’s stock valued at $557,000 after purchasing an additional 373 shares in the last quarter. Moran Wealth Management LLC grew its stake in shares of Transcat by 50.3% in the third quarter. Moran Wealth Management LLC now owns 3,793 shares of the scientific and technical instruments company’s stock worth $458,000 after acquiring an additional 1,269 shares in the last quarter. Intech Investment Management LLC acquired a new position in shares of Transcat in the third quarter worth $235,000. Charles Schwab Investment Management Inc. increased its position in shares of Transcat by 2.8% during the third quarter. Charles Schwab Investment Management Inc. now owns 74,832 shares of the scientific and technical instruments company’s stock worth $9,037,000 after acquiring an additional 2,008 shares during the period. Finally, Champlain Investment Partners LLC raised its stake in shares of Transcat by 22.1% in the third quarter. Champlain Investment Partners LLC now owns 409,500 shares of the scientific and technical instruments company’s stock valued at $49,455,000 after acquiring an additional 74,169 shares in the last quarter. Institutional investors and hedge funds own 98.34% of the company’s stock.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.